Vanguard Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $238M | Buy |
2,089,371
+33,639
| +2% | +$3.82M | ﹤0.01% | 1430 |
|
2025
Q1 | $216M | Sell |
2,055,732
-29,895
| -1% | -$3.14M | ﹤0.01% | 1448 |
|
2024
Q4 | $223M | Buy |
2,085,627
+115,005
| +6% | +$12.3M | ﹤0.01% | 1493 |
|
2024
Q3 | $197M | Buy |
1,970,622
+43,748
| +2% | +$4.38M | ﹤0.01% | 1550 |
|
2024
Q2 | $162M | Buy |
1,926,874
+42,762
| +2% | +$3.6M | ﹤0.01% | 1606 |
|
2024
Q1 | $138M | Buy |
1,884,112
+7,598
| +0.4% | +$555K | ﹤0.01% | 1701 |
|
2023
Q4 | $134M | Buy |
1,876,514
+24,653
| +1% | +$1.76M | ﹤0.01% | 1707 |
|
2023
Q3 | $111M | Sell |
1,851,861
-1,492
| -0.1% | -$89.4K | ﹤0.01% | 1750 |
|
2023
Q2 | $134M | Sell |
1,853,353
-5,261
| -0.3% | -$379K | ﹤0.01% | 1689 |
|
2023
Q1 | $137M | Buy |
1,858,614
+15,499
| +0.8% | +$1.14M | ﹤0.01% | 1657 |
|
2022
Q4 | $123M | Sell |
1,843,115
-1,031,728
| -36% | -$68.9M | ﹤0.01% | 1695 |
|
2022
Q3 | $154M | Buy |
2,874,843
+31,163
| +1% | +$1.67M | ﹤0.01% | 1540 |
|
2022
Q2 | $158M | Buy |
2,843,680
+74,276
| +3% | +$4.13M | ﹤0.01% | 1564 |
|
2022
Q1 | $194M | Buy |
2,769,404
+17,478
| +0.6% | +$1.23M | ﹤0.01% | 1573 |
|
2021
Q4 | $265M | Sell |
2,751,926
-8,906
| -0.3% | -$858K | 0.01% | 1432 |
|
2021
Q3 | $240M | Buy |
2,760,832
+317,612
| +13% | +$27.6M | 0.01% | 1493 |
|
2021
Q2 | $200M | Buy |
2,443,220
+9,478
| +0.4% | +$776K | 0.01% | 1632 |
|
2021
Q1 | $231M | Buy |
2,433,742
+95,085
| +4% | +$9.04M | 0.01% | 1509 |
|
2020
Q4 | $145M | Buy |
2,338,657
+47,500
| +2% | +$2.95M | ﹤0.01% | 1646 |
|
2020
Q3 | $136M | Sell |
2,291,157
-91,868
| -4% | -$5.46M | ﹤0.01% | 1513 |
|
2020
Q2 | $166M | Sell |
2,383,025
-172,077
| -7% | -$12M | 0.01% | 1395 |
|
2020
Q1 | $116M | Buy |
2,555,102
+38,371
| +2% | +$1.74M | ﹤0.01% | 1446 |
|
2019
Q4 | $164M | Sell |
2,516,731
-115,494
| -4% | -$7.51M | 0.01% | 1494 |
|
2019
Q3 | $163M | Sell |
2,632,225
-110,542
| -4% | -$6.86M | 0.01% | 1456 |
|
2019
Q2 | $195M | Sell |
2,742,767
-354,543
| -11% | -$25.2M | 0.01% | 1375 |
|
2019
Q1 | $243M | Buy |
3,097,310
+3,760
| +0.1% | +$295K | 0.01% | 1224 |
|
2018
Q4 | $262M | Sell |
3,093,550
-256,940
| -8% | -$21.8M | 0.01% | 1072 |
|
2018
Q3 | $574M | Buy |
3,350,490
+107,063
| +3% | +$18.3M | 0.02% | 721 |
|
2018
Q2 | $419M | Buy |
3,243,427
+130,815
| +4% | +$16.9M | 0.02% | 868 |
|
2018
Q1 | $321M | Buy |
3,112,612
+150,566
| +5% | +$15.5M | 0.01% | 989 |
|
2017
Q4 | $253M | Buy |
2,962,046
+120,603
| +4% | +$10.3M | 0.01% | 1139 |
|
2017
Q3 | $241M | Buy |
2,841,443
+49,309
| +2% | +$4.19M | 0.01% | 1129 |
|
2017
Q2 | $211M | Buy |
2,792,134
+86,882
| +3% | +$6.58M | 0.01% | 1196 |
|
2017
Q1 | $179M | Buy |
2,705,252
+118,932
| +5% | +$7.85M | 0.01% | 1295 |
|
2016
Q4 | $164M | Buy |
2,586,320
+86,698
| +3% | +$5.5M | 0.01% | 1303 |
|
2016
Q3 | $159M | Buy |
2,499,622
+69,772
| +3% | +$4.44M | 0.01% | 1264 |
|
2016
Q2 | $181M | Buy |
2,429,850
+179,227
| +8% | +$13.3M | 0.01% | 1111 |
|
2016
Q1 | $150M | Buy |
2,250,623
+89,053
| +4% | +$5.95M | 0.01% | 1189 |
|
2015
Q4 | $146M | Buy |
2,161,570
+24,744
| +1% | +$1.67M | 0.01% | 1206 |
|
2015
Q3 | $114M | Buy |
2,136,826
+34,070
| +2% | +$1.82M | 0.01% | 1342 |
|
2015
Q2 | $132M | Buy |
2,102,756
+472,712
| +29% | +$29.8M | 0.01% | 1346 |
|
2015
Q1 | $78.4M | Buy |
1,630,044
+31,446
| +2% | +$1.51M | 0.01% | 1670 |
|
2014
Q4 | $53.1M | Buy |
1,598,598
+123,838
| +8% | +$4.11M | ﹤0.01% | 1801 |
|
2014
Q3 | $43.2M | Sell |
1,474,760
-198,423
| -12% | -$5.82M | ﹤0.01% | 1880 |
|
2014
Q2 | $65M | Buy |
1,673,183
+95,448
| +6% | +$3.71M | 0.01% | 1695 |
|
2014
Q1 | $66.2M | Buy |
1,577,735
+487,668
| +45% | +$20.5M | 0.01% | 1638 |
|
2013
Q4 | $35.8M | Buy |
1,090,067
+204,235
| +23% | +$6.7M | ﹤0.01% | 1943 |
|
2013
Q3 | $23.9M | Buy |
885,832
+15,267
| +2% | +$412K | ﹤0.01% | 2047 |
|
2013
Q2 | $20.3M | Buy |
+870,565
| New | +$20.3M | ﹤0.01% | 2063 |
|